Dosing Protocol
Typical Dose 2 mg
Range 1 - 2 mg
Maintenance 2 mg daily
Pharmacokinetics
Half-Life 38 min
Onset 10 min
Peak 30 min
Duration 2.0 hrs
Bioavailability 90%
Primary Route Subcutaneous
Administration
Routes Subcutaneous
Injection Sites Abdomen
Needle Gauge 27G
Syringe Type Standard
Timing Morning, Fasted
Reconstitution
Diluent Sterile Water
Volume 2.1 mL
Stability 14 days refrigerated
Vial Sizes 1, 2 mg
Special Instructions
FDA-approved for HIV lipodystrophy. Inject into abdomen only. Do not inject into scar tissue.